A case of systemic sclerosis. Source: Nevit Dilmen / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)
Belimumab Granted Orphan Drug Designation for Systemic Sclerosis
Initially, belimumab (sold under the brand name BENLYSTA) was approved for the treatment of patients for lupus and lupus nephritis. It was the first FDA-approved biologic treatment within this indication.…
Continue Reading
Belimumab Granted Orphan Drug Designation for Systemic Sclerosis
